Sesiones científicas
Sesión de poster virtual
SP-05 Poster Session III Group A (Cáncer de próstata)
Fecha: Jueves 7 de marzo de 2024. Hora: 15:30-17:00
Moderadores: E. Linares, T. Vilaseca, A. Plata y C. Gil
Sala Salón A
P-36 - Searching Efficient Risk-Stratified Pathways for the Early Detection of Clinically Significant Prostate Cancer
Míriam Campistol; Juan Morote; Ángel Borque-Fernando; Luis M. Esteban; Ana Celma; Olga Mendez; Enrique Trilla
Hospital Universitario Vall d Hebron
Ver póster

P-37 - VALUE OF BASELINE PSA IN PREDICTING PROSTATE CANCER DIAGNOSIS AND DEATH. SPANISH ARM OF THE ERSPC.
Alba María García-Cano Fernández; Álvaro Páez Borda; Luis Llanes González; Marcos Luján Galán
Hospital Universitario de Getafe (1,3), Hospital Universitario de Fuenlabrada (2), Hospital Infanta Cristina (4)
Ver póster

P-38 - COMPARATIVE STUDY OF SERUM α2,3-SIALIC ACID PSA AND PHI (PROSTATE HEALTH INDEX) FOR HIGH-RISK PROSTATE CANCER DETECTION
Quevedo Monroy, S.; Caballero Carabantes, V.; Lobato Berrocal, G.F.; Castiglione Boquera, G.; Llop Escorihuela, E.; Peracaula Miró, R.; Aliaga Ayuni, C.; García De Manuel, G.; Tapia García, M.; Boix Orri, R.; Carrasco Cánovas, N.; Comet Batlle, J.
Servicio de Urología Hospital Universitari de Girona, Doctor Josep Trueta
Ver póster

P-39 - Predictors of positive outcome in Choline-PET for the diagnosis of prostate cancer recurrence or progression
Herrera Aranda, N; Ayerra Pérez, H; Arce Cuartango, P; San Martín Vilariño, P; Duque Martínez, I; García de Garayo Pires, N; Pinto Martín, R; Campà Bortoló, JM; Moctezuma Velázquez, J; Polvorinos García, L; Cachi Fuentes, G; Rodríguez López, S; Doménech López, P; Aizpiri Antoñana, L; Extramiana Cameno, J
Hospital Universitario Araba
Ver póster

P-40 - Prognostic and progression predictive factors in patients diagnosed with de novo metastatic hormone-sensitive prostate cancer
Gonzalo Aparicio, D.; San Cayetano Talegón, S.; Díaz López, D.; Simal Marcos M.; Zabala del Arco J.; Rey González S.; Santos Martín A.; Lacasa Viscasillas I.; Rábade Ferreiro A.; Loizaga Iriarte A.; Zubiaur Líbano M.C.
Hospital Universitario Basurto
Ver póster

P-41 - RISK FACTORS FOR BONE FRACTURES IN PATIENTS DIAGNOSED WITH LOCALIZED OR LOCALLY ADVANCED PROSTATE CANCER UNDERGOING ANDROGEN DEPRIVATION THERAPY.
Roldán Testillano, Rocío; Herranz Yagüe, J.A.; Alonso Grandes, María; Márquez Negro, A.M.; Cernuda Pereira, Casilda; Rendón Sánchez, J.D.; Martín Way, D.A.; Ripalda Ferretti, E.A.; Dorado Valentin, Montserrat; Ripalda Ferretti, E.A.; Páez Borda, Álvaro
Hospital Universitario de Fuenlabrada
Ver póster

P-42 - Analysis of Ultra-low PSA ≤0.02 three months after starting Apalutamide treatment in patients with Metastasic Hormonosensitive Prostate Cancer as a predictive factor of response and progression.
Curiel Elizondo, A; Garcia Rodriguez, J; Hevia Suarez, M; Gonzalez Ruiz De Leon, C; Sacristán Gonzalez, R; Moya Martín, C; Fernández Gómez, JM
Hospital Universitario Central de Asturias (HUCA)
Ver póster

P-43 - Analysis of Predictive Factors for Treatment Response in First-Line Therapy with Abiraterone and Enzalutamide in a Cohort of Patients with Metastatic Castration-Resistant Prostate Cancer.
Sánchez Pellejero, A.; Sanchís Bonet, A.; Vazquez Valdés, S.; Montuenga Fernandez, I.; Peral Parra, D.; Tamayo Ruiz, J.C.
Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid.
Ver póster

P-44 - RASH IN PATIENTS TREATED WITH APALUTAMIDE IN DIFFERENT PROSTATE CANCER SETTINGS. A REAL WORLD STUDY.
CARDENAS FERNÁNDEZ, ALEJANDRO; CABELLO GÓMEZ, ELOISA; MUÑOZ CALAHORRO, CARMEN; RIVERO BELENCHÓN, INÉS; MEDINA LÓPEZ, RAFAEL ANTONIO
HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO
Ver póster